Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium

被引：81
|
作者：
Margheri, Francesca [1 ]
Ceruso, Mariangela [2 ]
Carta, Fabrizio [2 ]
Laurenzana, Anna [1 ]
Maggi, Laura [3 ]
Lazzeri, Simone [4 ,5 ]
Simonini, Gabriele [2 ,4 ,5 ]
Annunziato, Francesco [3 ]
Del Rosso, Mario [1 ]
Supuran, Claudiu T. [2 ]
Cimaz, Rolando [2 ,4 ,5 ]
机构：
[1] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy
[2] Univ Florence, Neurofarba Dept, Via U Schiff 6, I-50019 Florence, Italy
[3] Univ Florence, Dept Expt & Clin Med, Florence, Italy
[4] Anna Meyer Childrens Hosp, Florence, Italy
[5] Univ Florence, Viale Pieraccini 24, I-50139 Florence, Italy
来源：
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2016年 / 31卷
关键词：
Carbonic anhydrase; juvenile idiopathic arthritis; synovium; INHIBITORS; FLUID; PH;
D O I：
10.1080/14756366.2016.1217857
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Juvenile idiopathic arthritis (JIA) is the most common form of chronic rheumatic disease affecting children worldwide, with some features similar to adult rheumatoid arthritis (RA). In the present study, we aim at investigating novel markers that will allow in the future for tailored, more personalized treatment strategies. Hence, taking notice of several reports proving the role of local acidosis as a causal link between inflammatory diseases and related pain, and the involvement of several carbonic anhydrases (CA, EC 4.2.1.1) isoforms in articular diseases, we evaluated in JIA patients the expression of these metalloenzymes. We identified that JIA patients show high levels of active CA IX and XII isoforms. Our results represent the first evidence of the identification of these enzymes as potential therapeutic targets and development of novel innovative therapies for arthritis, also considering that the two isoforms are validated antitumor targets.
引用
收藏
页码：60 / 63
页数：4
相关论文
共 50 条
  • [31] α,γ-Diketocarboxylic Acids and Their Esters Act as Carbonic Anhydrase IX and XII Selective Inhibitors
    Nocentini, Alessio
    Lucidi, Alessia
    Perut, Francesca
    Massa, Annamaria
    Tomaselli, Daniela
    Gratteri, Paola
    Baldini, Nicola
    Rotili, Dante
    Mai, Antonello
    Supuran, Claudiu T.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (04): : 661 - 665
  • [32] Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies
    Carta, Fabrizio
    Garaj, Vladimir
    Maresca, Alfonso
    Wagner, Jason
    Avvaru, Balendu Sankara
    Robbins, Arthur H.
    Scozzafava, Andrea
    McKenna, Robert
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (10) : 3105 - 3119
  • [33] Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII
    Barresi, Elisabetta
    Salerno, Silvia
    Marini, Anna Maria
    Taliani, Sabrina
    La Motta, Concettina
    Simorini, Francesca
    Da Settimo, Federico
    Vullo, Daniela
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (04) : 921 - 927
  • [34] o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII
    Guzel-Akdemir, Ozlen
    Akdemir, Atilla
    Isik, Semra
    Vullo, Daniela
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (06) : 1386 - 1391
  • [35] A series of benzensulfonamide derivatives as new potent carbonic anhydrase IX and XII inhibitors
    Nencetti, Susanna
    Cuffaro, Doretta
    Ciccone, Lidia
    Nocentini, Alessio
    Di Stefano, Miriana
    Poli, Giulio
    Macchia, Marco
    Tuccinardi, Tiziano
    Nuti, Elisa
    Supuran, Claudiu T.
    Rossello, Armando
    Orlandini, Elisabetta
    FUTURE MEDICINAL CHEMISTRY, 2025, 17 (03) : 271 - 285
  • [36] Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II
    Maresca, Alfonso
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) : 4511 - 4514
  • [37] Transmembrane carbonic anhydrase, MN/CA IX, is a potential biomarker for biliary tumours
    Saarnio, J
    Parkkila, S
    Parkkila, AK
    Pastoreková, S
    Haukipuro, K
    Pastorek, J
    Juvonen, T
    Karttunen, TJ
    JOURNAL OF HEPATOLOGY, 2001, 35 (05) : 643 - 649
  • [38] Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII
    Esirden, Ibrahim
    Ulus, Ramazan
    Aday, Burak
    Tanc, Muhammet
    Supuran, Claudiu T.
    Kaya, Muharrem
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (20) : 6573 - 6580
  • [39] Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII
    Ibrahim, Diaa A.
    Lasheen, Deena S.
    Zaky, Maysoun Y.
    Ibrahim, Amany W.
    Vullo, Daniela
    Ceruso, Mariangela
    Supuran, Claudiu T.
    Abou El Ella, Dalal A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (15) : 4989 - 4999
  • [40] Carbonic anhydrase inhibitors: Benzenesulfonamides incorporating cyanoacrylamide moieties are low nanomolar/subnanomolar inhibitors of the tumor-associated isoforms IX and XII
    Alafeefy, Ahmed M.
    Isik, Semra
    Abdel-Aziz, Hatem A.
    Ashour, Abdelkader E.
    Vullo, Daniela
    Al-Jaber, Nabila A.
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (06) : 1396 - 1403
12345